Literature DB >> 30830646

Does inappropriate prescribing affect elderly patients' quality of life? A study from a Malaysian tertiary hospital.

Muhammad Eid Akkawi1, Mohamad Haniki Nik Mohamed2, Mohd Aznan Md Aris3.   

Abstract

PURPOSE: To investigate the association between potentially inappropriate medication (PIM)/potential prescribing omission (PPO) and the health-related quality of life (HRQoL) among community-dwelling hospitalized elderly patients.
METHODS: This is a cross-sectional study that took place in a Malaysian tertiary hospital. Patients ≥ 65 years old with at least one medication on admission were recruited. The patients' prehospitalization medications were reviewed to identify PIMs/PPOs using version 2 of the STOPP/START criteria. HRQoL was assessed using the EuroQol-5 dimensions (EQ-5D) and EuroQol-visual analog scale (EQ-VAS). The association between the presence of PIM/PPO and the patients' HRQoL was analyzed using Chi-square and Mann-Whitney U tests. Multiple linear regression models were applied to determine the effect of exposure to PIM/PPO on the patients' HRQoL, adjusting for confounders.
RESULTS: Out of 517 patients who fulfilled the inclusion criteria, 502 patients (97%) accepted to be involved in the study and completed the HRQoL questionnaire. The mean (SD) age was 72.4 (5.9) years. 393 (78.3%) of the patients had problems in at least one EQ-5D dimension with pain/discomfort problem being the most reported complaint. The mean (SD) values of the EQ-5D index and the EQ-VAS were 0.734 (0.214) and 59.6 (14.2), respectively, which are lower than those seen in the general Malaysian population. PIM and PPO were found in 28.5% and 45.6% of the patients, respectively. No significant differences were found in the EQ-5D dimensions, EQ-5D index and EQ-VAS between patients who had PIM/PPO and those who did not. Age, sex, and comorbidities were significantly associated with the patients' HRQoL.
CONCLUSION: PIM and PPO are not uncommon among hospitalized elderly patients; however, it does not significantly affect their HRQoL as measured by the EQ-5D-3L instrument.

Entities:  

Keywords:  EQ-5D-3L; Elderly patients; Health-related quality of life; Hospitalization; Potentially inappropriate prescribing

Mesh:

Year:  2019        PMID: 30830646     DOI: 10.1007/s11136-019-02153-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  5 in total

Review 1.  The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.

Authors:  Georgie B Lee; Christopher Etherton-Beer; Sarah M Hosking; Julie A Pasco; Amy T Page
Journal:  Ther Adv Drug Saf       Date:  2022-07-04

2.  Factors Associated with Health-Related Quality of Life in Community-Dwelling Older Adults: A Multinomial Logistic Analysis.

Authors:  Encarnación Blanco-Reina; Jenifer Valdellós; Ricardo Ocaña-Riola; María Rosa García-Merino; Lorena Aguilar-Cano; Gabriel Ariza-Zafra; Inmaculada Bellido-Estévez
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

3.  Prevalence of Drug-Related Problems and Complementary and Alternative Medicine Use in Malaysia: A Systematic Review and Meta-Analysis of 37,249 Older Adults.

Authors:  Chee-Tao Chang; Ju-Ying Ang; Md Asiful Islam; Huan-Keat Chan; Wee-Kooi Cheah; Siew Hua Gan
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25

4.  Relationship between potentially inappropriate medications and functional prognosis in elderly patients with distal radius fracture: a retrospective cohort study.

Authors:  Takako Nagai; Masahiro Nagaoka; Koji Tanimoto; Yoshiaki Tomizuka; Hiroshi Uei; Kazuyoshi Nakanishi
Journal:  J Orthop Surg Res       Date:  2020-08-12       Impact factor: 2.359

Review 5.  Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis.

Authors:  Alemayehu B Mekonnen; Bernice Redley; Barbora de Courten; Elizabeth Manias
Journal:  Br J Clin Pharmacol       Date:  2021-05-18       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.